Publication | Open Access
Golimumab induction and maintenance for moderate to severe ulcerative colitis: results from GO-COLITIS (Golimumab: a Phase 4, UK, open label, single arm study on its utilization and impact in ulcerative Colitis)
35
Citations
12
References
2018
Year
NCT02092285; 2013-004583-56.
| Year | Citations | |
|---|---|---|
Page 1
Page 1